Saturday, September 22, 2018

Technology Drives Better HCV Outcomes

Gastroenterology & Endoscopy News

Technology Drives Better HCV Outcomes 

Boston—Using ingestible sensors, mobile apps, dashboards and other high-tech tools, pharmacists are working with providers to improve adherence rates among patients with hepatitis C virus, according to two studies presented at the 2018 Academy of Managed Care Pharmacy’s Managed Care & Specialty Pharmacy Meeting.

With an electronic clinical dashboard, pharmacists are able to help manage 2,400 patients in the HCV program created by Kaiser Permanente Washington, in Seattle. Specialty and clinical pharmacists collaborate with providers and patients to provide treatment that optimizes outcomes and reduces waste. Pharmacists with expertise in HCV work with providers to choose optimal regimens; monitor clinical response, laboratory results and adverse effects; and adjust therapy as needed. The specialty pharmacy dispenses medications and helps obtain financial support for patients. The pharmacists track treatment completion rates and sustained virologic response 12 weeks (SVR-12) after completion of treatment through the dashboard (abstract B10).

No comments:

Post a Comment